- UroToday Home
- Pelvic Health & Reconstruction
The Latest Research in Overactive Bladder
Recent Abstracts
-
Effectiveness of Combined Behavioral and Drug Therapy for Overactive Bladder Symptoms in Men: A Randomized Clinical Trial.Overactive BladderJanuary 19, 2020
-
Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactOveractive BladderJanuary 19, 2020
-
Update on non-invasive treatment for female overactive bladder.Overactive BladderJanuary 13, 2020
-
Effect of mirabegron on erectile function in sexually active men with bothersome overactive bladder symptoms.Overactive BladderJanuary 13, 2020
-
Overactive Bladder: Clinical Updates in Women's Health Care Primary and Preventive Care Review.Overactive BladderJanuary 4, 2020
-
Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients.Overactive BladderJanuary 2, 2020
-
Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population.Overactive BladderDecember 29, 2019
-
The role of prescription drugs in female overactive bladder syndrome-A population-wide cohort study.Overactive BladderDecember 26, 2019
-
Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study.Overactive BladderDecember 22, 2019
-
Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report.Overactive BladderDecember 19, 2019
Beyond the Abstracts
-
Women with Overactive Bladder Exhibit More Unhealthy Toileting Behaviors: a Cross-Sectional Study - Beyond the AbstractOveractive BladderJanuary 9, 2020
-
A Prospective Study to Evaluate Efficacy Using the Nuro™ Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients with Overactive Bladder Syndrome - Beyond the AbstractOveractive BladderJuly 28, 2019
-
Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder - Beyond the AbstractOveractive BladderJuly 12, 2019
-
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment - Beyond the AbstractOveractive BladderMay 14, 2019
-
Abdominal versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator - Beyond the AbstractOveractive BladderMarch 7, 2019
-
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, Design, and Methodology– Beyond the AbstractOveractive BladderJune 11, 2018
-
Association Between Coronary Artery Disease Severity and Overactive Bladder in Geriatric Patients: Beyond the AbstractOveractive BladderOctober 27, 2017
-
Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers: Beyond the AbstractOveractive BladderOctober 13, 2017
-
What is the true catheterization rate after intravesical onabotulinumtoxinA injection: Beyond the AbstractOveractive BladderAugust 23, 2017
-
Real-Time Changes in Brain Activity During Sacral Neuromodulation for Overactive Bladder: Beyond the AbstractOveractive BladderJuly 25, 2017
